EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The effect of zinc deficiency and application of recombinant bovine growth hormone on plasma growth hormone and insulin like growth factor-1 of calves



The effect of zinc deficiency and application of recombinant bovine growth hormone on plasma growth hormone and insulin like growth factor-1 of calves



Journal of Animal Physiology & Animal Nutrition 70(3): 149-158



In a fifteen week breek and a ten week fattening experiment with calves, nor a control group and a zinc deficient group were treated with exogen bovine growth hormone. For that purpose 48 male Brown Swiss calves were distributed to four treatments and housed in individual boxes. The animals of the breed experiment maintained a milk replacer for the first seven weeks with a zinc content of 6.7 mg/kg and for the whole experiment a basal diet with 7.8 mg zinc/kg. The zinc content of the milk replacer in the fattening experiment was 5.7 mg zinc/kg. Blood samples were taken in the weeks, 1, 13, and 15 in the breed experiment and in the week 10 in the fattening experiment by puncture of the jugular vain using the vacationer system. In these blood samples growth hormone and insulin like growth factor-1 were analysed. The concentration of growth hormone was neither in the breed- nor in the fattening experiment influenced by the low zinc intake and the application of exogene bovine growth hormone. This results show, that not a reduced concentration of growth hormone is responsible for the reduced growth due to zinc deficiency. The concentration of the insulin like growth factor-1 decreased in the breed experiment due to zinc deficiency about 54% for the not with exogene growth hormone treated animals and about 21% for the treated animals. In the fattening experiment the reduction amounted to 69% respectively 48% due to zinc deficiency. The application of exogene growth hormone increased the insulin like growth factor-1 in the breed experiment about 20% when the zinc intake was high and about 104% when the zinc intake was deficient. In the fattening experiment the increase amounted to 17% respectively 92% for the deficient animals. So possibly a reduced concentration of plasma insulin like growth factor-1 is responsible for the growth retardation seen during zinc deficiency.

(PDF emailed within 1 workday: $29.90)

Accession: 002518576

Download citation: RISBibTeXText



Related references

Effect of zinc sulphate and zinc methionine on growth, plasma growth hormone concentration, growth hormone receptor and insulin-like growth factor-I gene expression in mice. Clinical and Experimental Pharmacology & Physiology 32(4): 273-278, 2005

Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case report. Journal of Medical Case Reports 4(): 305-305, 2010

Effect of growth hormone releasing hormone on plasma growth hormone in relation to magnitude and duration of growth hormone deficiency in 26 children and adults with isolated growth hormone deficiency or multiple pituitary hormone deficiencies evidence for hypothalamic growth hormone releasing hormone deficiency. Journal of Clinical Endocrinology & Metabolism 58(6): 1043-1049, 1984

Effects of feed reduction on plasma growth hormone and insulin-like growth factor-1 concentrations and the growth hormone response to growth hormone releasing factor in calves. Journal of Reproduction & Development 42(SUPPL ): 132-134, 1996

Effect of timing of growth hormone administration on plasma growth-hormone-binding activity, insulin-like growth factor-I and growth in children with a subnormal spontaneous secretion of growth hormone. Hormone Research (Basel) 39(5-6): 188-191, 1993

Idiopathic growth hormone deficiency and growth hormone deficiency secondary to hypothalamic germinoma effect of single and repeated administration of human growth hormone releasing factor on plasma growth hormone level and endogenous human growth hormone releasing factor like immunoreactivity level in cerebrospinal fluid. Journal of Clinical Endocrinology & Metabolism 60(2): 269-278, 1985

Effects of zinc deficiency and application of exogen recombinant bovine growth hormone on performance and parameter of zinc status of calves. Journal of Animal Physiology & Animal Nutrition 70(2): 61-71, 1993

Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age. Hormone Research 71 Suppl 1: 39-45, 2009

Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes. Acta Paediatrica . Supplement 383: 137-142, 1992

The effect of growth hormone treatment alone or growth hormone with supplemental zinc on growth rate, serum, and urine zinc and copper concentrations and hair zinc concentration in patients with growth hormone deficiency. Journal of the American College of Nutrition 2(2): 133-140, 1983

Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency. Journal of Bone and Mineral Research 12(2): 210-220, 1997

Thymulin, zinc and insulin-like growth factor-I (IGF-I) activity before and during recombinant growth hormone (rec-GH) therapy in children and adults with GH deficiency. Journal of Endocrinological Investigation 19(9): 630-637, 1996

Thymulin, zinc and insulin-like growth factor-I activity before and during recombinant growth hormone therapy in children and adults with GH deficiency. Journal of Endocrinological Investigation 19(9): 630-637, 1996

Body changes in adolescent patients with growth hormone receptor deficiency receiving recombinant human insulin-like growth factor I and luteinizing hormone-releasing hormone analogue: preliminary results. Acta Paediatrica . Supplement 399: 133-136, 1994

The associations between the growth hormone/insulin-like growth factor-1 axis, adiponectin, resistin and metabolic profile in children with growth hormone deficiency before and during growth hormone treatment. Acta Biochimica Polonica 65(2): 333-340, 2018